Analyst upgrades: BT, LUM, COGN, THO and WPI
Posted Sep 28th 2007 11:00AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Watson Pharmaceuticals (WPI)
.gif)
MOST NOTEWORTHY: BT Group, Luminent Mortage, Cognos, Thor Industries and Watson Pharmaceuticals were today's noteworthy upgrades:
- ING Group upgraded shares of BT Group (NYSE: BT) to Hold from Sell to reflect the company's more stable revenue trend and improving cash flow generation.
- Deutsche Bank upgraded shares of Luminent Mortgage Capital (NYSE: LUM) to Hold from Sell, as they believe the company's portfolio is beginning to stabilize and its liquidity has improved.
- Goldman upgraded Cognos Inc (NASDAQ: COGN) to Buy from Neutral following its Q2 report.
- Thor Industries (NYSE: THO) was raised to Sector Perform from Underperform at RBC Capital Markets. The firm's checks indicate strengthening backlog and lower promotional spending.
- Roth Capital believes Watson Pharmaceuticals (NYSE: WPI) is about to enter a growth phase with Paul Bisaro at the helm and is positive on Silodosin potential. The firm upgraded shares to Buy from Hold.
OTHER UPGRADES:
Tags: analyst, bank of the ozarks, BankOfTheOzarks, bt, bt group, BtGroup, cno, cogn, cognos, conseco, har, harman, lum, luminent, ozrk, packagin corp, PackaginCorp, pkg, smurfit-stone, sscc, tho, thor, upgrade, watson, wpi
Closing Bell: When We All Love the PIIGS (NBG, SQNM, PG, ERTS, KO)
Serious Money: Cheapest Stocks List Shrinks from 26 to 21
Chasing Value: Hasbro Earnings Makes My Point
